Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Compare Safety and Pharmacokinetic(PK) Properties of CJ-30039 and Lipidil Supra and To Investigate Food-effect on PK of CJ-30039 in Healthy Male Volunteers

This study has been completed.
Information provided by (Responsible Party):
CJ HealthCare Corporation Identifier:
First received: December 24, 2011
Last updated: August 1, 2012
Last verified: December 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2012
  Primary Completion Date: April 2012 (Final data collection date for primary outcome measure)